메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색
질문

논문 기본 정보

자료유형
학술저널
저자정보
이성남 (국립목포대학교)
저널정보
서강대학교 법학연구소 법과기업연구 법과기업연구 제9권 제1호(통권 제22호)
발행연도
2019.4
수록면
51 - 85 (35page)
DOI
10.35505/sjlb.2019.04.9.1.51

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색
질문

초록· 키워드

오류제보하기
It appears that the coverage of cancer claims is ultimately the need for hospitalization for the treatment of cancer, and that it is concluded whether by the hospitalization in the course of cancer treatment or after the treatment is closed, and the gravity of the patient’s condition, as shown in the Accepted and rejected cases. In conclusion, there seems to be no inherent difference between the phrase “for the purpose of treating cancer” and the phrase “for the direct purpose of treating cancer,” which eventually modifies the hospitalization.
The need for hospitalization should be considered as a risk requirement for cancer treatment and as a requirement for cancer treatment. The treatment of cancer is treated through administration of anti-cancer drugs, radiation treatment, surgery, etc. In addition, the treatment of side effects associated with the treatment of cancer, or adverse events occurring in the cancer itself, can be considered to be included in direct cancer treatment.
Hospitalization means that a patient enters and stays in a hospital for a certain period of time to cure a disease, and the need for hospitalization is considered as a separate requirement in the sense of hospitalization for the direct purpose of treating cancer.
The need for hospitalization is required to be considered as a separate requirement in the sense of direct purpose hospitalization. However, when determining the requirements for hospitalization, it is necessary to broadly recognize the requirements for hospitalization by considering symptoms, difficulties in treatment or patient condition, depending on the broad-ranging criteria. If hospitalization is interpreted as essential to receive anti-cancer medication, there is room to unfairly reduce the scope of hospital admission.

목차

국문초록
Ⅰ. 서설
Ⅱ. 암보험 관련 분쟁사례 분석
Ⅲ. 암보험약관의 개정내용에 대한 검토
Ⅳ. 보험소비자를 위한 생산적·포용적 서비스 제고 방안
Ⅴ. 결론
참고문헌
Abstract

참고문헌 (11)

참고문헌 신청

이 논문과 연관된 판례 (5)

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

이 논문과 함께 이용한 논문

최근 본 자료

전체보기

댓글(0)

0

UCI(KEPA) : I410-ECN-0101-2019-360-000757191